Skip to main content
TipRanks
Go Ultimate75% OFF

John Lubniewski Insider Profile

4 Followers

John Lubniewski, President & CEO, Director at HTG Molecular Diagnostics, holds 14.13K shares in HTG Molecular Diagnostics (Ticker: HTGMQ).

John Lubniewski's Trading History

HTGMQ
HTG Molecular Diagnostics
Dec 13, 2022President & CEO, DirectorUninformative Buy420.00―
HTGMQ
Insider Shares: 14.13K (0.13%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 13, 2022Uninformative Buy$420.001,000$0.42―
Jul 01, 2022Uninformative Sell$62.8361$1.03―
Jun 15, 2022Uninformative Buy$470.001,000$0.47―
Apr 04, 2022Uninformative Sell$86.1862$1.39―
Dec 15, 2021Uninformative Buy$3.56K1,000$3.56―

You May Also Like

John Lubniewski insider profile FAQ

What stocks does John Lubniewski hold?
John Lubniewski holds: HTGMQ stocks.
What was John Lubniewski’s latest transaction?
John Lubniewski’s latest transaction was an Uninformative Buy of $420.00.
What is John Lubniewski's role in HTG Molecular Diagnostics?
John Lubniewski's role in HTG Molecular Diagnostics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.